Canada Life’s PhenomeX Inc. Common Stock CELL Stock Holding History

Canada Life’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,092	Closed	-$6K	–	2400
2022 Q3	$6K	Buy	2,092 +547	+35%	+$2.33K	﹤0.01%	2377
2022 Q2	$8K	Buy	1,545 +560	+57%	+$2.93K	﹤0.01%	2392
2022 Q1	$7K	Buy	985 +501	+104%	+$4.14K	﹤0.01%	2457
2021 Q4	$9K	Buy	+484	New	+$10.4K	﹤0.01%	2455

Other funds holding CELL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NIMC

Nierenberg Investment Management Company Camas, Washington $201M AUM 36.3% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Canada Life's CELL Position: Q4 2022 in Review

Canada Life sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 2,092 shares — an estimated $6K sold.

Canada Life first reported a position in CELL in Q4 2021 and held it in 4 quarters. The position peaked at $9K in Q4 2021. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

Canada Life reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Canada Life sold 2,092 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $6K.
Canada Life first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Canada Life's PhenomeX Inc. Common Stock position peaked at $9K in Q4 2021.
117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Canada Life's 13F filing for Q4 2022, filed 10 Feb 2023.